CN101301328B - Medicament for treating pyogenic skin infection and carbuncle-abscess - Google Patents
Medicament for treating pyogenic skin infection and carbuncle-abscess Download PDFInfo
- Publication number
- CN101301328B CN101301328B CN2008100553131A CN200810055313A CN101301328B CN 101301328 B CN101301328 B CN 101301328B CN 2008100553131 A CN2008100553131 A CN 2008100553131A CN 200810055313 A CN200810055313 A CN 200810055313A CN 101301328 B CN101301328 B CN 101301328B
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- borax
- carbuncle
- abscess
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 206010007247 Carbuncle Diseases 0.000 title claims abstract description 19
- 206010000269 abscess Diseases 0.000 title claims abstract description 17
- 206010040872 skin infection Diseases 0.000 title claims description 17
- 239000000843 powder Substances 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 23
- 229910021538 borax Inorganic materials 0.000 claims abstract description 22
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 22
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 22
- 239000002674 ointment Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 21
- 239000007766 cera flava Substances 0.000 claims description 17
- 241000282894 Sus scrofa domesticus Species 0.000 claims description 16
- 241001161070 Calomela Species 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000002893 slag Substances 0.000 claims description 6
- 241000972155 Moschus Species 0.000 claims 6
- -1 Cinnabaris 1-2 part Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 208000027418 Wounds and injury Diseases 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 208000033809 Suppuration Diseases 0.000 abstract description 6
- 208000014674 injury Diseases 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 206010048038 Wound infection Diseases 0.000 abstract description 4
- 230000002980 postoperative effect Effects 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 208000004210 Pressure Ulcer Diseases 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 abstract description 2
- 210000000981 epithelium Anatomy 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 2
- 241000402754 Erythranthe moschata Species 0.000 abstract 2
- 241001071917 Lithospermum Species 0.000 abstract 2
- 229940116229 borneol Drugs 0.000 abstract 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 2
- 229910052956 cinnabar Inorganic materials 0.000 abstract 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 2
- 229910052602 gypsum Inorganic materials 0.000 abstract 2
- 239000010440 gypsum Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000037257 muscle growth Effects 0.000 abstract 1
- 210000004498 neuroglial cell Anatomy 0.000 abstract 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 11
- 230000029663 wound healing Effects 0.000 description 11
- 238000002651 drug therapy Methods 0.000 description 10
- 230000003115 biocidal effect Effects 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 229940097572 chloromycetin Drugs 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 108010040201 Polymyxins Proteins 0.000 description 2
- 206010036410 Postoperative wound infection Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000031650 Surgical Wound Infection Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000001699 lower leg Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 206010056377 Bone tuberculosis Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- 241000029132 Paronychia Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine, in particular to a drug for treating sores and carbuncle abscess, which solves the problem that the prior other drugs cannot have good curative effect on treating the sores and the carbuncle abscess. The drug is made from the following raw medicinal materials in portion by weight: 20 to 35 portions of gypsum, 1 to 2 portions of cinnabar, 0.5 to 1 portion of borax, 0.5 to 1 portion of borneol, 0.3 to 0.5 portion of musk, 25 to 35 portions of lard, 3 to 5 portions of yellow wax, and 2 to 3 portions of lithospermum. A method for making the drug comprises the following steps that: the gypsum, the cinnabar, the borax, the borneol and the musk are mixed with the drugs and then ground to get powder; the lard is heated and melted; and ointment obtained by decocting the yellow wax and the lithospermum are added in. The drug eliminates putridity, promotes muscle growth, promotes blood circulation to remove blood stasis, diminishes inflammation to stop pain, promotes the hyperplasia and division of glial cells, the cell regeneration of epithelial tissues and blood circulation, etc. The drug mainly plays a role in treating carbuncle abscess, sores, bedsores and injuries from falls, and has unique efficacy especially for wound infection and suppuration or postoperative nonunion.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specially a kind of medicine for the treatment of pyogenic skin infection and carbuncle-abscess.
Background technology
Ulcer sores, decubital ulcer, traumatic injury, the particularly disunion of a specified duration of surgical wound infection suppurates are puzzlement doctor's difficult problems always.In daily medical practice, generally be because the traumatic infection antibacterial causes for the understanding of this disease, so this type of disease of use antibiotic therapy just becomes first-selection.Yet antibiotic also has its drawback.Particularly for example dosage is excessive or administration time when long in improper use, and antibiotic can cause all untoward reaction, and what have remains serious.For example, streptomycin, kanamycin can cause dizzy, tinnitus, deafness; Gentamycin, kanamycin, polymyxin, vancomycin, bacitracin can damage kidney; Gastrointestinal reactions such as erythromycin, lincomycin, doxycycline can cause anorexia, feel sick, vomiting, stomachache, diarrhoea; Ciprofloxacin can have slight gastrointestinal side effect; Chloromycetin can cause leukopenia even aplastic anemia.Research is proof also, and streptomycin, chloromycetin, erythromycin, cephalosporin and polymyxin B can suppress immunologic function, weakens Abwehrkraft des Koepers.Many antibiotic also can cause irritating erythra.Under a few cases, antibiotic also can kill a person.What should watch out for especially is to the patient of penicillin anaphylaxis, when accepting the penicillin treatment, anaphylactic shock may take place and death.Above the aplastic anemia that causes of said chloromycetin, the renal damage that gentamycin, polymyxin, kanamycin etc. cause also can reach and causes people's order of severity desperately.The more important thing is the life-time service antibiotic therapy, make antibacterial that the selectivity variation take place, the bacterial resistance ability is more and more strong, and antibiotic is actual effect gradually, and the result is the deterioration that many medicines are lost control of the state of an illness on the contrary in treatment.So seek a kind of target of pursuing that can replace antibiotic medicine to become medical worker in motherland Chinese medicine field.
Summary of the invention
The present invention treats the problem of the unsatisfactory curative effect that exists in the pyogenic skin infection and carbuncle-abscess and a kind of medicine for the treatment of pyogenic skin infection and carbuncle-abscess is provided in order to solve existing other medicines treatment.
The present invention is realized that by following technical scheme a kind of medicine for the treatment of pyogenic skin infection and carbuncle-abscess is to be made according to part by weight by the following raw materials according medicine:
Gypsum Fibrosum 20-35 part, Cinnabaris 1-2 part, Borax 0.5-1 part, Borneolum Syntheticum 0.5-1 part, Moschus 0.3-0.5 part, Adeps Sus domestica 25-35 part, Cera Flava 3-5 part, Radix Arnebiae (Radix Lithospermi) 2-3 part,
Method for making: earlier Gypsum Fibrosum, Cinnabaris, Borax, Borneolum Syntheticum is ground into powder respectively, again Moschus is mixed with said medicine to grind then and obtain powder, again the Adeps Sus domestica heating is melted, put into Cera Flava, decoct 30-60 minute adding Radix Arnebiae (Radix Lithospermi) and decocted again 2-10 minute, remove the Radix Arnebiae (Radix Lithospermi) slag then, obtaining ointment in the quiet 10-40 of putting hour. usage: get an amount of powder according to big or small the dipping in dried absorbent cotton of wound surface, very thin being coated with is spread on wound surface, gets an amount of above-mentioned ointment again and is applied on the jute paper, the about 0.5-1 millimeter of thickness, in cold water, soak, be affixed on the wound place, bind up with gauze and get final product.One day twice.
Material medicine of the present invention also comprises the Calomelas of 0.03-0.05 part, and Calomelas is ground into powder, and again and Gypsum Fibrosum, Cinnabaris, the powder that Borax, Borneolum Syntheticum are ground into respectively mix the back and is ground into powder, all the other step unanimities with Moschus.
On the basis of above-mentioned prescription, the medicine with treatment pyogenic skin infection and carbuncle-abscess of optimum efficiency of the present invention is to be made according to part by weight by the following raw materials according medicine: 30 parts in Gypsum Fibrosum, 2 parts in Cinnabaris, 1 part of Borax, 1 part of Borneolum Syntheticum, 0.3 part in Moschus, 35 parts of Adeps Sus domesticas, 5 parts in Cera Flava, 3 parts of Radix Arnebiae (Radix Lithospermi)s.0.04 part of the consumption that also comprises Calomelas.
Gypsum Fibrosum, hot, sweet, Great Cold.Go into lung, stomach warp.Clearing away heat-fire, the convergence granulation promoting.Be used for diseases such as epidemic febrile disease, the big heat of lung stomach, hyperpyrexia, thirsty, fidgety, full and large pulse.Cinnabaris: sweet, cold, poisonous.Effect: tranquilizing mind, heat-clearing and toxic substances removing makes eye bright.Cure mainly: control demented, the palpitation with fear, vexed, the insomnia, dizzy, blurred vision, toxic swelling, skin infection, scabies.
Borax, sweet, salty, cold.Function cures mainly, heat clearing away, and expectorant, detoxifcation, anticorrosion.Be used for acute tonsillitis, pharyngolaryngitis, stomatitis, gingivitis, otitis media, conjunctival congestion and swelling pain, tinea versicolor.Function: heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, removing the necrotic tissue and promoting granulation.
Borneolum Syntheticum, arduous, cold.Effect: the refreshment of having one's ideas straightened out, the stagnated fire of loosing, removing nebula makes eye bright, reducing swelling and alleviating pain.Cure mainly: control the apoplexy locked mouth, calentura coma ， Jing Epilepsy expectorant fan, deafness with qi stagnation, sore throat, aphtha, otitis media, carbuncle, hemorrhoid, conjunctivitis, enterobiasis.Moschus, nature and flavor suffering, temperature.Function is had one's ideas straightened out, the meridian dredging, reducing swelling and alleviating pain.Cure mainly diseases such as frightened carbuncle stupor, apoplexy syncope due to accumulation of phlegm, cold-evil's diarrhoea, swollen ulcer drug, traumatic injury.Adeps Sus domestica sweet in the mouth, cool in nature, nontoxic; Tonify deficiency arranged, moisturize, the antidotal effect; Can control diseases such as internal organs are dull and heavy, stool is unfavorable, cough caused by dryness, chapped skin; Pharmaceutically acceptablely take, endure cream orally or go into pill.Outer as lubricate coating affected part.
Cera Flava has another name called Cera Flava, and meridian distribution of property and flavor is sweet, tepor.Function cures mainly, and astringent therapy is held back skin ulcer, granulation promoting, pain relieving.Be used for ulcer being unable to heal outward, ecthyma erosion, wound, burn.The Radix Arnebiae (Radix Lithospermi) nature and flavor: cold in nature, sweet in the mouth, salty.Gui Jing: GUIXIN, Liver Channel.Function cures mainly removing heat from blood, invigorates blood circulation the detoxifcation rash.Be used for that heat in blood poison is contained, purple black, the measles without adequate eruption of macule, skin infection, eczema, burn due to hot liquid or fire.Clearing away heat and cooling blood is used for measles, calentura skin eruption, eczema, hematuria, stranguria with blood, dysentery, skin infection, erysipelas, burn, constipation with heat retention.Calomelas, the nature and flavor suffering, cold, poisonous.Function cures mainly parasite killing, counteracting toxic substances, diuretic, relieving constipation.Control scabies, scrofula, syphilis, primary sore, skin ulcer, edema, tympanites, defecation is closed.The Calomelas external has bactericidal action.
Gypsum Fibrosum has clearing away heat-fire Great Cold in the compositions, the effect of convergence granulation promoting, and the Borneolum Syntheticum clearing away heat to alleviate pain, the Moschus reducing swelling and alleviating pain, the blood circulation promoting and dispersing pathogen accumulation fit applications plays the effect of blood circulation promoting and blood stasis dispelling, blood circulation promoting, and poison is separated with pus, and slough is come off, and new meat is day growth early; Can remove the rotten and let fresh grow, convergence promotes new granulation tissue's growth.The pharmacological action of this group medicine: putrefaction-removing granulation-promoting, activating blood circulation to dissipate blood stasis, anti-inflammatory analgetic promotes effects such as the division of neurogliocyte hypertrophy, epithelial tissue cell regeneration and blood circulation.Above medicine comprehensive function cures mainly: ulcer sores, and decubital ulcer, traumatic injury particularly wound infection is suppurated, or postoperative disunion of a specified duration has unique curative effect.
1, the effect of this medicine putrefaction-removing granulation-promoting is strong especially, can very fast rotten tissue in the wound surface be got rid of after the medication, makes new granulation tissue ramp, promotes wound healing.
2, anti-infection property is good especially, and wound surface little during the medication generally need not used antibiotic therapy.
3, because this medicine contains somatomedin, promote to organize the epithelial cell regeneration strong especially, can make preventing from scar behind the wound healing, nature is short, without any side effects repair time.Obtained good curative effect through clinical checking repeatedly for many years.
It below is result of use clinical statistics table of the present invention
In sum, the present invention is used for the treatment of ulcer sores, decubital ulcer, traumatic injury, particularly wound infection are suppurated, or postoperative disunion of a specified duration has unique curative effect, cure rate reaches more than 95 percent and is without any side effects, has replenished the debridement of doctor trained in Western medicine postoperative, sews up, the transfusion of having an injection, the misery that wound disunion of a specified duration etc. bring to patient.
Model case:
1, Guan Han inscription man is 40 years old, south, footpath between fields people from town, and because of the right crus of diaphragm mechanical injuries, wound suppuration disunion of a specified duration, it is more than to suppurate, and hospital prepares to do transplant operation to him, with wound healing about January after the Drug therapy of the present invention.
2, Wang Ya is bright male 52 years old, people from Henan, and right hand middle finger mechanical damage, the preparation amputation is made a definite diagnosis by wound suppuration disunion of a specified duration hospital, heals substantially with 20 days left and right sides wounds of Drug therapy of the present invention.
3, grandson turns round and look at beautiful women 48 years old, people from Xi'an, and behind the operation on gallbladder, the disunion of a specified duration of suppurating of four months wound infections is with Drug therapy of the present invention wound healing after month.
4, the Seedling woman pricked 62 years old in party, and the people is crossed on the wind mound, the tuberculosis of spine infection suppurates, and with Drug therapy of the present invention 40 days, wound healing.
5, the blue woman of Li Yue is 32 years old, big royal people, and liquefaction of fat behind the cesarotomy, wound disunion of a specified duration, with Drug therapy of the present invention after one month, wound healing.
6, Hou Li Rong woman is 32 years old, people from Yuncheng, and acute mastitis becomes pus, used after operation Drug therapy of the present invention wound healing after 20 days.
7, Zhang Jinhong man is 13 years old, people from Pinglu, and bubon is suppurated, after the surgical incision evacuation of pus, with Drug therapy of the present invention wound healing after January.
8, Lee builds and sends out man 76 years old, and the Ruicheng County people because of hemiplegia, is unable to leave the bed throughout the year, and the many places pressure ulcer is arranged on one's body, and is obvious with wound healing after the Drug therapy of the present invention.
9, Wang Hongyan woman is 23 years old, eastern black earth people, and right crus of diaphragm thumb paronychia is after operation removes finger nail, with Drug therapy of the present invention wound healing after January.
10, Xiao built people man 46 years old, people from north pass, and the disunion of a specified duration of hemorrhoid postoperative wound infection is with Drug therapy of the present invention wound healing after 20 days.
The specific embodiment
Embodiment 1, a kind of medicine for the treatment of pyogenic skin infection and carbuncle-abscess makes by the following raw materials according medicine and makes according to part by weight: 20 parts in Gypsum Fibrosum, 2 parts in Cinnabaris, 0.5 part of Borax, 1 part of Borneolum Syntheticum, 0.3 part in Moschus, 35 parts of Adeps Sus domesticas, 3 parts in Cera Flava, 3 parts of Radix Arnebiae (Radix Lithospermi)s, method for making: earlier Gypsum Fibrosum, Cinnabaris, Borax, Borneolum Syntheticum is ground into powder respectively, adds Moschus again and mixes with said medicine then to grind and obtain powder, the Adeps Sus domestica heating is melted again, put into Cera Flava, decoct 30 minutes adding Radix Arnebiae (Radix Lithospermi)s and decocted 2 minutes again, remove the Radix Arnebiae (Radix Lithospermi) slag then, quiet putting obtained ointment in 10 hours.Material medicine can also add 0.03 part Calomelas, and Calomelas is ground into powder, and again and Gypsum Fibrosum, Cinnabaris, the powder that Borax, Borneolum Syntheticum are ground into respectively mix the back and is ground into powder, all the other step unanimities with Moschus.
Embodiment 2, and a kind of medicine for the treatment of pyogenic skin infection and carbuncle-abscess makes by the following raw materials according medicine and makes according to part by weight: 30 parts in Gypsum Fibrosum, 2 parts in Cinnabaris, 1 part of Borax, 1 part of Borneolum Syntheticum, 0.3 part in Moschus, 35 parts of Adeps Sus domesticas, 5 parts in Cera Flava, 3 parts of Radix Arnebiae (Radix Lithospermi)s.Method for making: earlier Gypsum Fibrosum, Cinnabaris, Borax, Borneolum Syntheticum are ground into powder respectively, add Moschus again and mix then common the grinding with said medicine and obtain powder, again the Adeps Sus domestica heating is melted, put into Cera Flava, decoct 45 minutes adding Radix Arnebiae (Radix Lithospermi)s and decocted 5 minutes again, remove the Radix Arnebiae (Radix Lithospermi) slag then, quiet putting obtained ointment in 24 hours.Material medicine can also add 0.04 part Calomelas, and Calomelas is ground into powder, and again and Gypsum Fibrosum, Cinnabaris, the powder that Borax, Borneolum Syntheticum are ground into respectively mix the back and is ground into powder, all the other step unanimities with Moschus.
Embodiment 3, a kind of medicine for the treatment of pyogenic skin infection and carbuncle-abscess makes by the following raw materials according medicine and makes according to part by weight: 35 parts in Gypsum Fibrosum, 1 part in Cinnabaris, 1 part of Borax, Borneolum Syntheticum 0.5-part, 0.5 part in Moschus, 25 parts of Adeps Sus domesticas, 5 parts in Cera Flava, 2 parts of Radix Arnebiae (Radix Lithospermi)s, method for making: earlier Gypsum Fibrosum, Cinnabaris, Borax, Borneolum Syntheticum is ground into powder respectively, and said medicine is mixed and then added common grinding of Moschus and obtains powder, the Adeps Sus domestica heating is melted again, put into Cera Flava, decoct 60 minutes adding Radix Arnebiae (Radix Lithospermi)s and decocted 10 minutes again, remove the Radix Arnebiae (Radix Lithospermi) slag then, quiet putting obtained ointment in 60 hours.Material medicine can also add 0.05 part Calomelas, and Calomelas is ground into powder, and again and Gypsum Fibrosum, Cinnabaris, the powder that Borax, Borneolum Syntheticum are ground into respectively mix the back and is ground into powder, all the other step unanimities with Moschus.
Claims (4)
1. medicine for the treatment of pyogenic skin infection and carbuncle-abscess, it is characterized in that: be to make according to part by weight: Gypsum Fibrosum 20-35 part by the following raw materials according medicine, Cinnabaris 1-2 part, Borax 0.5-1 part, Borneolum Syntheticum 0.5-1 part, Moschus 0.3-0.5 part, Adeps Sus domestica 25-35 part, Cera Flava 3-5 part, Radix Arnebiae (Radix Lithospermi) 2-3 part, method for making: earlier Gypsum Fibrosum, Cinnabaris, Borax, Borneolum Syntheticum are ground into powder respectively, adding Moschus again mixes with said medicine then to grind and obtains powder, again the Adeps Sus domestica heating is melted, put into Cera Flava, decoct 30-60 minute adding Radix Arnebiae (Radix Lithospermi) and decocted again 2-10 minute, remove the Radix Arnebiae (Radix Lithospermi) slag then, obtained ointment in the quiet 10-40 of putting hour.
2. the medicine of treatment pyogenic skin infection and carbuncle-abscess according to claim 1 is characterized in that: be to be made according to part by weight by the following raw materials according medicine: 30 parts in Gypsum Fibrosum, 2 parts in Cinnabaris, 1 part of Borax, 1 part of Borneolum Syntheticum, 0.3 part in Moschus, 35 parts of Adeps Sus domesticas, 5 parts in Cera Flava, 3 parts of Radix Arnebiae (Radix Lithospermi)s.
3. medicine for the treatment of pyogenic skin infection and carbuncle-abscess, it is characterized in that: be to make according to part by weight: Gypsum Fibrosum 20-35 part, Cinnabaris 1-2 part, Borax 0.5-1 part by the following raw materials according medicine, Borneolum Syntheticum 0.5-1 part, Moschus 0.3-0.5 part, Adeps Sus domestica 25-35 part, Cera Flava 3-5 part, Radix Arnebiae (Radix Lithospermi) 2-3 part, 0.03-0.05 the Calomelas of part, method for making: earlier Gypsum Fibrosum, Cinnabaris, Borax, Borneolum Syntheticum is ground into powder respectively, adds Moschus again and mixes with said medicine then to grind and obtain powder, the Adeps Sus domestica heating is melted again, put into Cera Flava, decoct and added Radix Arnebiae (Radix Lithospermi) in 30-60 minute and decocted again 2-10 minute, remove the Radix Arnebiae (Radix Lithospermi) slag then, obtained ointment in the quiet 10-40 of putting hour.
4. the medicine of treatment pyogenic skin infection and carbuncle-abscess according to claim 3 is characterized in that: be to be made according to part by weight by the following raw materials according medicine: 30 parts in Gypsum Fibrosum, 2 parts in Cinnabaris, 1 part of Borax, 1 part of Borneolum Syntheticum, 0.3 part in Moschus, 35 parts of Adeps Sus domesticas, 5 parts in Cera Flava, 3 parts of Radix Arnebiae (Radix Lithospermi)s, 0.04 part Calomelas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100553131A CN101301328B (en) | 2008-06-27 | 2008-06-27 | Medicament for treating pyogenic skin infection and carbuncle-abscess |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100553131A CN101301328B (en) | 2008-06-27 | 2008-06-27 | Medicament for treating pyogenic skin infection and carbuncle-abscess |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101301328A CN101301328A (en) | 2008-11-12 |
| CN101301328B true CN101301328B (en) | 2011-06-29 |
Family
ID=40111545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100553131A Expired - Fee Related CN101301328B (en) | 2008-06-27 | 2008-06-27 | Medicament for treating pyogenic skin infection and carbuncle-abscess |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101301328B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784241A (en) * | 2012-06-15 | 2012-11-21 | 叶菊仙 | Pasty medicament for treating initial neck carbuncle |
| CN107982398A (en) * | 2017-11-24 | 2018-05-04 | 王志强 | A kind of putrefaction-removing granulation-promoting paste and preparation method thereof |
| CN108186712A (en) * | 2018-03-16 | 2018-06-22 | 唐天左 | The production method of SHENGJI BAIYU GAO |
| CN116019867A (en) * | 2022-12-05 | 2023-04-28 | 雷晓琴 | Pearl skin-promoting ointment and preparation method thereof |
-
2008
- 2008-06-27 CN CN2008100553131A patent/CN101301328B/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 李灿.生肌法治疗溃疡的研究进展.中医外治杂志.2005,14(6),5-7. |
| 高晓芬 |
| 高晓芬;李灿.生肌法治疗溃疡的研究进展.中医外治杂志.2005,14(6),5-7. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101301328A (en) | 2008-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100518794C (en) | Burn cream | |
| CN101310748B (en) | Ointment for treating empyrosis | |
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN102727696A (en) | Ointment for treating burn and preparation method of ointment | |
| CN101164574B (en) | Medicine for treating burns and scalds and its preparation method | |
| CN101301328B (en) | Medicament for treating pyogenic skin infection and carbuncle-abscess | |
| CN102526411B (en) | Chinese medicinal composition for treating surgical wound | |
| CN102266441B (en) | Chinese medicinal ointment for treating burns and scalds | |
| CN101966250B (en) | Externally applied Chinese medicament for treating burn and manufacturing method thereof | |
| CN101703651A (en) | Medicament for treating diabetic gangrene | |
| CN101062085B (en) | Condyloma acuminata treating medicine | |
| CN102988555A (en) | Skin and tissue cream for burns | |
| CN103055013B (en) | Combination drug of curing rash and burn and preparation method thereof | |
| CN102379963B (en) | Skin wound treating ointment and preparation method thereof | |
| CN102846782A (en) | External traditional Chinese medicine ointment for treating burns and scalds and preparation method thereof | |
| CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| CN101653541A (en) | Medicinal preparation for treating burn and scald | |
| CN1966007A (en) | Medicinal plaster for treating burn and scald | |
| CN101829234B (en) | Bothriospermum chinense and downy groundcherry fruitor herb ointment for treating burns and scalds and preparation method thereof | |
| CN108245577B (en) | Ointment for relieving pain, eliminating swelling and promoting tissue regeneration of burn and preparation method thereof | |
| CN111603537B (en) | Traditional Chinese medicine composition and oil agent for treating carbuncle-abscess sores and ulcers and preparation method and application of traditional Chinese medicine composition and oil agent | |
| CN105832909A (en) | Traditional Chinese medicine preparation for treating necrotic ulcer of skin | |
| CN102920818B (en) | Formula of medicine for treating burn, scald and cold injury | |
| CN101181338A (en) | Chinese medicine prescription for curing empyrosis and preparation method thereof | |
| CN105943659A (en) | Composition used for treating surgical inflammation and burn, preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 |